Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

<p>Abstract</p> <p>Background</p> <p>The mechanisms by which chronic hepatitis B is completely resolved through antiviral therapy are unknown, and the contribution of acquired T cell immunity to hepatitis B surface antigen (HBsAg) seroclearance has not been investigated...

Full description

Bibliographic Details
Main Authors:	Zhu Xiaolin, Sun Jian, Wang Zhanhui, Chen Jinjun, Zhang Junchang, Zhou Bin, Hu Xiaoxiong, Ma Shiwu, Liang Minfeng, Abbott William, Hou Jinlin
Format:	Article
Language:	English
Published:	BMC 2011-02-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/8/1/69

Similar Items

Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen
by: Chueh-An Chen, et al.
Published: (2007)

Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
by: Hyun Woong Lee, et al.
Published: (2020-04-01)

Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.
by: Ming-Hua Zheng, et al.
Published: (2014-01-01)

Using Machine Learning Algorithms to Predict Hepatitis B Surface Antigen Seroclearance
by: Xiaolu Tian, et al.
Published: (2019-01-01)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.
by: Tae Hyung Kim, et al.
Published: (2018-01-01)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
by: Hideaki Taniguchi, et al.
Published: (2020-08-01)

Incidence and Determinants of Seroclearance of Hepatitis B e Antigen and Its Association with Risk of Liver Cirrhosis and HCC
by: Hsiu-Lien Hung, et al.
Published: (2010)

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma
by: Sara Naimimohasses, et al.
Published: (2017-12-01)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
by: Jeong Won Jang, et al.
Published: (2021-01-01)

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
by: Ming-Lun Yeh, et al.
Published: (2011-01-01)

HBS Ag seroclearance and seroconversion time in patients with chronic hepatitis B infection
by: jila Masrour-Roudsari, et al.
Published: (2020-03-01)

Features of immune response during antiviral therapy in patients with chronic hepatitis B
by: WANG Weibin, et al.
Published: (2016-10-01)

Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report
by: Chau-Ting Yeh, et al.
Published: (2018-02-01)

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.
by: Huei-Ru Cheng, et al.
Published: (2013-01-01)

Antiviral therapy for chronic hepatitis B: current status and perspectives
by: FAN Rong, et al.
Published: (2016-11-01)

Virologic and Host Genetic Mechanisms of HBsAg Seroclearance in Patients with Chronic Hepatitis B Virus Infection
by: Huei-Ru Cheng, et al.
Published: (2014)

Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection
by: Jing Cao, et al.
Published: (2020-01-01)

Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model
by: Jian Zu, et al.
Published: (2017-06-01)

Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
by: Matthew Zirui Tay, et al.
Published: (2019-02-01)

A study of cellular immunity and immunoregulation to liver-derived-antigens in patients with auto-immune chronic active hepatitis
by: O'Brien, Charles Joseph
Published: (1987)

Interaction of Hepatitis Delta Antigen and Cellular Factors
by: Wen-Hung Huang, et al.
Published: (2001)

Innate Antiviral Immune Responses to Hepatitis B Virus
by: David Durantel, et al.
Published: (2010-07-01)

Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy
by: Ying Xu, et al.
Published: (2017-09-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
by: Tai-Long Chien, et al.
Published: (2016-01-01)

Cellular immune responses to histocompatibility antigens in the rat
by: Chisholm, P. M.
Published: (1978)

HBsAg seroclearance or seroconversion induced by peg-interferon alpha and lamivudine or adefovir combination therapy in chronic hepatitis B treatment: a meta-analysis and systematic review
by: Yun Zhang, et al.

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
by: Satoko Matsunaga, et al.
Published: (2020-03-01)

Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau.
by: Bin Zhou, et al.
Published: (2011-01-01)

Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.
by: Xia Jiang, et al.
Published: (2014-01-01)

Severe hepatitis B reactivation during direct-acting antiviral treatment in “the absence” of hepatitis B surface antigen
by: Lydia Sastre, et al.
Published: (2019-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
by: Teresa Broquetas, et al.
Published: (2017-01-01)

Identification of Hepatitis Delta Antigen – Associated and/or – Regulated Cellular Factors
by: Ching-Huang Ho, et al.
Published: (2007)

An epidemic Zika virus isolate suppresses antiviral immunity by disrupting antigen presentation pathways
by: Ryan D. Pardy, et al.
Published: (2021-06-01)

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C.
by: Sheng Feng Lin, et al.
Published: (2020-01-01)

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?
by: Alessandro Loglio, et al.
Published: (2020-01-01)

Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B.
by: Xiaotao Jiang, et al.
Published: (2011-01-01)

Antiviral Immunity in Amphibians
by: Jacques Robert, et al.
Published: (2011-10-01)

Mitophagy in Antiviral Immunity
by: Hongna Wang, et al.
Published: (2021-09-01)

Cellular immune responses in hepatitis C virus infection
by: Al-Jarrah, Hatim A.
Published: (2002)

New antivirals for hepatitis B
by: Vicente Soriano
Published: (2018-05-01)